Viewing Study NCT01259102


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-01-29 @ 3:59 AM
Study NCT ID: NCT01259102
Status: COMPLETED
Last Update Posted: 2012-09-03
First Post: 2010-12-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
Sponsor: Purdue Pharma LP
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2000-11
Start Date Type: None
Primary Completion Date: 2001-03
Primary Completion Date Type: ACTUAL
Completion Date: 2001-03
Completion Date Type: ACTUAL
First Submit Date: 2010-12-10
First Submit QC Date: None
Study First Post Date: 2010-12-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-01-13
Results First Submit QC Date: None
Results First Post Date: 2011-02-07
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-08-27
Last Update Post Date: 2012-09-03
Last Update Post Date Type: ESTIMATED